DataExpo GAKG DeepReport Navigation

Copyright©2015-2024 Acemap, Inc. Shanghai Jiao Tong University. All rights reserved.

沪ICP备18028330号

MF

Maria Frigerio

National University of Rosario

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Enrico Ammirati

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

Manlio Cipriani

Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione

Fabrizio Oliva

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

Claudio Russo

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

Andrea Garascia

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

Gabriella Masciocco

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

Tiziano Colombo

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

Fabio Maria Turazza

Fondazione IRCCS Istituto Nazionale dei Tumori

Giuseppe Bruschi

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

Enrico Perna

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

Cooperative Institutions

Istituti di Ricovero e Cura a Carattere Scientifico

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

Netherlands Heart Institute

University of Milan

Ospedale Maggiore

Manitoba Health

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

University of Milano-Bicocca

Centro Cardiologico Monzino

Society of Thoracic Surgeons

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

One-Year Survival of Patients Treated With Left Ventricular Assist Device (LVAD) as Bridge to Transplantation (BTT) or Bridge to Candidacy (BTC) vs. Heart Transplantation (HTx) With Donors Older Than 55 Years

The Journal of Heart and Lung Transplantation (2015)

Manlio Cipriani Enrico Ammirati Marisa Varrenti Francesca Macera Luca D’Angelo

Candidacy

Destination therapy

10.1016/j.healun.2015.01.253

Cite

Citations (0)

Two-year Survival After Continuous-flow Left Ventricular Assist Device Versus Heart Transplantation: An Italian Single Centre Perspective

The Journal of Heart and Lung Transplantation (2014)

Enrico Ammirati Fabrizio Oliva Tiziano Colombo Claudio Russo Manlio Cipriani

Interquartile range

Destination therapy

10.1016/j.healun.2014.01.564

Cite

Citations (0)

Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology

European Journal of Heart Failure (2018)

María G. Crespo‐Leiro Marco Metra Lars H. Lund Davor Miličić Maria Rosa Costanzo

Decompensation

Canadian Cardiovascular Society

Destination therapy

10.1002/ejhf.1236

Cite

Citations (712)

Drugs for Left Ventricular Remodeling in Heart Failure

The American Journal of Cardiology (2005)

Maria Frigerio Elèna Roubina

Ventricular remodeling

Contractility

10.1016/j.amjcard.2005.09.060

Cite

Citations (97)

Long‐term effects of primary graft dysfunction after heart transplantation

Journal of Cardiac Surgery (2022)

Fabrizio Settepani Giovanna Pedrazzini Guido Maria Olivieri Bruno Merlanti Aldo Cannata

We studied the incidence of primary graft dysfunction (PGD), its impact on in-hospital and follow-up outcomes and searched for independent risk factors.During an 18-year period, 508 individuals underwent heart transplantation at our institution. Patients were diagnosed with none, mild, moderate or severe PGD according to ISHLT criteria.Thirty-eight patients (7.5%) met the ISHLT criteria for mild PGD, 92 (18.1%) for moderate PGD and 23 (4.5%) for severe PGD. Patients were classified into none/mild PGD (77.4%) and moderate/severe PGD (22.6%) groups. In-hospital mortality was 12.4% (7.8% for none/mild PGD and 28.7% for moderate/severe PGD; p < .001). Survival at 1, 5, and 15 years was 85.5 ± 1.9% versus 67.2 ± 4.5%, 80 ± 2.2% versus 63.5 ± 4.7%, and 60.4 ± 3.6% versus 45.9 ± 8.4%, respectively (p < .001). Excluding the events occurring during the first month of follow-up, survival was comparable between the two groups (93.1 ± 1.4% vs. 94.7 ± 2.6 at 1 year and 65.6 ± 3.8% vs. 70.4 ± 10.4% at 15 years, respectively; p = .88). Upon multivariate logistic regression analysis preoperative mechanical circulatory support (odds ratio [OR] = 5.86) and preoperative intra-aortic balloon pump (IABP) (OR = 9.58) were independently associated with moderate/severe PGD.Our results confirm that PGD is associated with poor in-hospital outcome. The poor outcome does not extend beyond the first month of follow-up, with comparable survival between patients with none/mild PGD and moderate/severe PGD in the short and long-term. Mechanical circulatory support and preoperative IABP were found to be independent risk factors for moderate/severe PGD.

10.1111/jocs.16364

Cite

Citations (2)

L'ecocardiografia nella valutazione del paziente con insufficienza cardiaca: parametri di valutazione del trattamento farmacologico.

The Cardiology (1995)

Maria Frigerio Edoardo Gronda B Andreuzzi Maurizio Mangiavacchi Gabriella Masciocco

Cite

Citations (0)

Sex Differences in LVAD Implantation Strategies and Associated Outcomes from the TransAtlantic Registry on VAD and Transplant (TRAVIATA)

Journal of Cardiac Failure (2019)

Quan M. Bui S. Gary Michela Brambatti Oscar Ö. Braun Enrico Ammirati

10.1016/j.cardfail.2019.07.466

Cite

Citations (0)

Organ Allocation Around the World: Insights From the ISHLT International Registry for Heart and Lung Transplantation

The Journal of Heart and Lung Transplantation (2014)

Josef Stehlik Lynne W. Stevenson Leah B. Edwards María G. Crespo‐Leiro Juan F. Delgado

10.1016/j.healun.2014.08.001

Cite

Citations (43)

Heart transplantation in patients with eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome)

The Journal of Heart and Lung Transplantation (2014)

Matthieu Groh Gabriella Masciocco E. Kirchner Arnt V. Kristen Carlo Pellegrini

Granulomatosis with polyangiitis

Immunosuppression

Microscopic polyangiitis

10.1016/j.healun.2014.02.023

Cite

Citations (48)

Management of cardiogenic shock in acute decompensated chronic heart failure: The ALTSHOCK phase II clinical trial

American Heart Journal (2018)

Nuccia Morici Fabrizio Oliva Silvia Ajello Miriam Stucchi Alice Sacco

Interquartile range

10.1016/j.ahj.2018.07.009

Cite

Citations (41)

More pages